Eli Lilly And reported $15.62B in Current Liabilities for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
ALKERMES ALKS:US $ 438.52M 23.84M
Amgen AMGN:US $ 12618M 268M
AstraZeneca AZN:LN 21815M 925M
Astrazeneca AZN:US $ 21815M 925M
Baxter International BAX:US $ 3916M 26M
Biogen BIIB:US $ 5018M 1071.4M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Catalent CTLT:US $ 1046M 1M
Coherus Biosciences CHRS:US $ 140.75M 12.99M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Endo International Ordinary Shares ENDP:US $ 1181.67M 194.47M
Gilead Sciences GILD:US $ 9220M 662M
GlaxoSmithKline GSK:LN 37835M 13557M
Glaxosmithkline GSK:US $ 37835M 13557M
Horizon Pharma HZNP:US $ 791.06M 34.12M
Intercept Pharmaceuticals ICPT:US $ 151.43M 0.39M
JAZZ PHA JAZZ:US $ 705.44M 31.97M
Lannett LCI:US $ 94.36M 5.1M
Medtronic MDT:US $ 12394M 3467M
Neurocrine Biosciences NBIX:US $ 285.7M 32.2M
Novartis NOVN:VX SF 27646M 2161M
Novartis NVS:US $ 27646M 2161M
Perrigo Ordinary Shares PRGO:US $ 1014.6M 33.3M
Phibro Animal Health PAHC:US $ 187.1M 20.47M
Prestige Brands PBH:US $ 155.35M 11.93M
Regeneron Pharmaceuticals REGN:US $ 3033.9M 26.3M
Revance Therapeutics RVNC:US $ 77.23M 6.16M
Teva Pharmaceutical Industries TEVA:US $ 10996M 617M
United Therapeutics UTHR:US $ 331.5M 38.9M
Zoetis ZTS:US $ 3051M 17M